Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margitta Retz

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Urologia Internationalis|June 10, 2009
Influence of body mass index on operability, morbidity and disease outcome following radical cystectomyTobias Maurer, Jean Maurer, Margitta Retz, et al.
European Urology|March 24, 2004
Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCRMargitta Retz, Jan Lehmann, Celine Szysnik, et al.
Urologie (Heidelberg, Germany)|June 1, 2023
[Sequential therapy of advanced bladder cancer after prior perioperative systemic treatment : Recommendations from the Interdisciplinary Bladder Carcinoma Working Group (IABC) of the DKG e. V.]Margitta Retz, Florian P Kirchhoff, Gunhild von Amsberg, et al.
World Journal of Urology|May 28, 2013
The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancerThomas Horn, Barbara Ladwein, Tobias Maurer, et al.
Plos One|November 24, 2011
S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancerRoman Nawroth, Florian Stellwagen, Wolfgang A Schulz, et al.
Anticancer Research|October 25, 2017
Vinflunine in the Treatment of Upper Tract Urothelial Carcinoma - Subgroup Analysis of an Observational StudyHendrik Heers, Patrick DE Geeter, Peter J Goebell, et al.
Urologic Oncology|March 9, 2020
Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissectionMatthias M Heck, Florestan J Koll, Margitta Retz, et al.
European Urology|February 16, 2006
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell linesJan Lehmann, Margitta Retz, Sukhvinder S Sidhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancerThomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
World Journal of Urology|October 21, 2022
Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancerJulia Wagner, Ricarda Simon, Jakob Wolf Büchler, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Urologia Internationalis|June 10, 2009
Influence of body mass index on operability, morbidity and disease outcome following radical cystectomyTobias Maurer, Jean Maurer, Margitta Retz, et al.
European Urology|March 24, 2004
Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCRMargitta Retz, Jan Lehmann, Celine Szysnik, et al.
Urologie (Heidelberg, Germany)|June 1, 2023
[Sequential therapy of advanced bladder cancer after prior perioperative systemic treatment : Recommendations from the Interdisciplinary Bladder Carcinoma Working Group (IABC) of the DKG e. V.]Margitta Retz, Florian P Kirchhoff, Gunhild von Amsberg, et al.
World Journal of Urology|May 28, 2013
The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancerThomas Horn, Barbara Ladwein, Tobias Maurer, et al.
Plos One|November 24, 2011
S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancerRoman Nawroth, Florian Stellwagen, Wolfgang A Schulz, et al.
Anticancer Research|October 25, 2017
Vinflunine in the Treatment of Upper Tract Urothelial Carcinoma - Subgroup Analysis of an Observational StudyHendrik Heers, Patrick DE Geeter, Peter J Goebell, et al.
Urologic Oncology|March 9, 2020
Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissectionMatthias M Heck, Florestan J Koll, Margitta Retz, et al.
European Urology|February 16, 2006
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell linesJan Lehmann, Margitta Retz, Sukhvinder S Sidhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancerThomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
World Journal of Urology|October 21, 2022
Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancerJulia Wagner, Ricarda Simon, Jakob Wolf Büchler, et al.
Pageof 10